This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsAurobindo Pharma arm Unit III facility gets USFDA OAI status
Orchid Pharma announces Q4 results with 71.60 percent growth in annual PATOrchid Pharma announces Q4 results with 71.60 percent growth in annual PAT
NPPA Expert Committee Recommends Pricing for Abbotts Clarithromycin Tablet, Cautions Firm Over Form ErrorNPPA Fixes Retail Price Of 37 Formulations, Details
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA completes inspection at Gland Pharma Visakhapatnam facility with Zero 483 observations
GSK arm Tesaro initiates litigation against AnaptysBioZantac not a cause of woman's cancer, says jury
Emcure to Market Roches CellCept, Mircera, Neorecormon Under New India PactBiocon, Handok ink pact for commercialization of chronic weight management Liraglutide in South...
Apollo Hospitals Pharmacy-Digital Demerger Is Strategic, Not Linked to Family Dispute, MD ClarifiesShareholders of Taro Pharma approve merger with Sun Pharma
Discontinue Olaparib Tablets Marketing For Specific Cancers: CDSCODiscontinue Olaparib Tablets Marketing For Specific Cancers: CDSCO
Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo NordiskEmcure Pharma, Gennova Biopharma resolves all legal disputes with HDT Bio
SC Refuses Interim Relief to Piramal Pharma in Dahej Unit ClosurePiramal Pharma Lexington facility successfully completes USFDA Inspection
Gland Pharma profit rises 12 percent to Rs 184 crore in Q2Gland Pharma net profit jumps over two-fold to Rs 192 crore in Q4
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XRGranules India Promoter sells 3.09 pecent stake for Rs 304 crore
X